Date: June 20, 2026
Regulatory Action Disclosure
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a suspension order for a Drug License from the Maharashtra Food & Drug Administration.
Details of Regulatory Action
Authority: Assistant Commissioner & Licensing authority, Food & Drug Administrations, MH, PUNE Mr. R.V. Pongale
Nature of Action: Suspension of Drug License for 10 days for store situated at Chowk Saswad, Pune
Date of Order Receipt: June 20, 2026
Regulatory Basis: Action taken under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945
Financial Impact: Potential Revenue Loss of ₹2.68 lakhs (quantifiable monetary impact)
Disclosure Compliance
- SEBI Listing Regulations
- SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026
- Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
The information will be available on the company's website (www.medplusindia.com) and stock exchange websites (www.bseindia.com and www.nseindia.com).